title: Vasculitis: an update.
abstract: The systemic vasculitides are uncommon but serious diseases. Early recognition can be difficult because they mimic many conditions. Aggressive immunosuppression is toxic but effective; a targeted approach with biological agents may improve the outcome.
authors.affiliation: Professor of Rheumatology and Consultant Rheumatologist in the National Institute for Health Research Musculoskeletal Biomedical Research Unit, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Nuffield Orthopaedic Centre, Oxford OX3 7LD.
authors.forename: Raashid A
authors.initials: RA
authors.lastname: Luqmani
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D003937:Diagnosis, Differential; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D011379:Prognosis; D014657:Vasculitis / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy*
chemical_list: D000893:Anti-Inflammatory Agents; D007155:Immunologic Factors